| Dr Harry D Leseur, PHARMD | |
|
271 Main St, Chester, CA 96020 | |
| (530) 258-2261 | |
| (530) 258-1999 |
| Full Name | Dr Harry D Leseur |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 271 Main St, Chester, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497895544 | NPI | - | NPPES |
| 43447 | Other | CA | PHARMACIST LICENSE |
| 10611 | Other | NV | PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 43447 (California) | Primary |
| 183500000X | Pharmacist | 10611 (Nevada) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harry D Leseur, PHARMD Po Box 21, Chester, CA 96020-0021 Ph: (530) 258-2261 | Dr Harry D Leseur, PHARMD 271 Main St, Chester, CA 96020 Ph: (530) 258-2261 |
News Archive
Humans could learn from how plants handle stress. Federica Brandizzi, Michigan State University plant biologist, is using a grant from the National Institutes of Health to study how plants overcome stress as they grow. These pathways used to overcome stress are a key to growth. Without them plants, and animals, would die.
Around one in four people encounter bowel or bladder instability during their lives, so to show support for World Continence Week, and also Men's Health Awareness Week, NRS Healthcare have created a guide confronting the unspoken subject of men's incontinence.
The vitamin biotin is essential for the growth of bacteria. The researchers show that there is not enough biotin present in human plasma to support the growth of antibiotic-resistant pathogens.
Results were presented at the 13th World Conference on Lung Cancer in San Francisco. The single arm Phase II study evaluated the therapeutic agent EC145 and the molecular imaging agent EC20 in 42 patients with advanced adenocarcinoma of the lung. Forty percent of patients involved in the clinical trial had already failed at least four chemotherapy regimens prior to enrollment in the study.
› Verified 3 days ago